Regenosca’s patented technology TissueSpan results in off-the-shelf and ready to use implants to avoid a second surgical site in soft tissue repair surgeries. They are engineered to be a noninvasive alternative to patient’s own tissue grafts that are currently used in clinics. Proof-of-concept is validated in an ongoing First-in-Man study where implants were successfully used to repair urethral strictures. The gold standard treatment is the use of patient’s own inner mouth tissue. Avoiding tissue harvesting means less pain, lower risks of complications, and shorter surgery times. TissueSpan implants will render soft tissue repair less invasive and fill the gap of missing biomaterials.
Location: Switzerland, Vaud, Lausanne
Employees: 1-10
Total raised: $1.13M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.07.2024 | Pre-Seed | $1.13M | - |
Mentions in press and media 11
| Date | Title | Description |
| 31.07.2024 | Regenosca: Pioneering a New Era in Urethral Reconstruction | In the world of medical technology, innovation is the lifeblood that fuels progress. Regenosca, a Swiss MedTech startup, is at the forefront of this revolution. With its groundbreaking TissueSpan technology, the company is reshaping the lan... |
| 31.07.2024 | Regenosca secures CHF 1M Pre-Seed funding to advance endoscopic delivery of innovative TissueSpan bio-implants | Regenosca develops bio-implants that help the body heal by attracting and organizing its cells. The MedTech startup's TissueSpan technology acts as a temporary, naturally absorbed bridge to replace diseased tissue, restoring health. Regenos... |
| 26.07.2024 | Fresh funding for Regenosca | Regenosca developed and patented TissueSpan, a technology which allows for the creation of off-the-shelf and ready-to-use regenerative implants that serve as a noninvasive alternative to patients’ tissue grafts. The current gold-standard p... |
| 06.06.2024 | Innosuisse recognizes startups envisioned to transform the medical sector | Startups that apply for the Innosuisse Certificate after completing the Innosuisse Core Coaching program undergo a comprehensive evaluation of their innovation capabilities, financial readiness for external funding, and management structur... |
| 19.07.2023 | Swiss Medtechs seek growth opportunities in Boston | |
| 27.11.2020 | Regenosca wins CHF 150,000 to support bladder reconstruction | |
| 27.11.2020 | Regenosca wins CHF 150,000 to support bladder reconstruction | To date, surgeons use a tissue patch harvested from the patient’s intestines to reconstruct the bladder. Using the patient’s donor tissue is readily available and more biocompatible; however, creating a second operative site is burdensome a... |
| 12.11.2020 | Medtech and Cleantech startups get boosted | |
| 12.11.2020 | Medtech and Cleantech startups get boosted | The InnoBooster program of the Gebert Rüf Foundation aims at speeding up innovative, science-based deeptech businesses that have high market potential, and have already entered the Venture Kick process. The selection committee has selected ... |
| 17.05.2019 | Here is the 4th MassChallenge Switzerland Cohort | Normal 0 21 false false false FR-CH X-NONE X-NONE |
Show more